Ampio Pharmaceuticals (AMPE)

$0.00 0.00 (N/A)
Market Cap 3,000.00
Revenue (ttm) 0.00
Net Income (ttm) -8.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 800
Avg Vol 1,220
Day's Range N/A - N/A
Shares Out 1.14M
Stochastic %K 0%
Beta 4.92
Analysts Strong Buy
Price Target $44.98

Company Profile

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Industry: Biotechnology
Sector: Healthcare
Phone: 720 437 6500
Address:
9800 Mount Pyramid Court, Suite 400, Englewood, United States
11thestate
11thestate Jun. 24 at 10:28 AM
$AMPE investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #Ampio $AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jun. 12 at 10:47 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
MrVenndram
MrVenndram Jun. 7 at 12:25 PM
$AMPE 4,000% What is latest on assets, intellectual property etc?
1 · Reply
11thestate
11thestate Jun. 4 at 12:13 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate May. 30 at 1:18 PM
$AMPE stockholders filed a claim against Ampio for allegedly withholding negative trial results and misrepresenting the efficacy of its AP-013 clinical study. You can join this case to be notified about any new information: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
Optiongenius
Optiongenius May. 27 at 11:40 PM
$AMPE WHERES TOPQUEER 😂
1 · Reply
11thestate
11thestate May. 23 at 11:23 PM
$AMPE investors, if you follow us, you already knew about it. This is the good news you needed about $AMPE today. Go check it out. #AmpioPharmaceuticals #AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 16 at 12:20 PM
$AMPE agreed to a $3M settlement with investors over claims it misled them about the efficacy of its drug Ampion. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.15 per share — but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 16 at 11:49 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of Ampion in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between October 31, 2022 and January 13, 2025. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.15 per share — but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 15 at 12:07 PM
$AMPE stockholders filed a claim against Ampio Pharmaceuticals for misleading them about the efficacy results and disclosures related to its AP-013 clinical trial. You can join this case to be notified about potential recovery: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
Latest News on AMPE
No data available.
11thestate
11thestate Jun. 24 at 10:28 AM
$AMPE investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #Ampio $AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jun. 12 at 10:47 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
MrVenndram
MrVenndram Jun. 7 at 12:25 PM
$AMPE 4,000% What is latest on assets, intellectual property etc?
1 · Reply
11thestate
11thestate Jun. 4 at 12:13 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate May. 30 at 1:18 PM
$AMPE stockholders filed a claim against Ampio for allegedly withholding negative trial results and misrepresenting the efficacy of its AP-013 clinical study. You can join this case to be notified about any new information: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
Optiongenius
Optiongenius May. 27 at 11:40 PM
$AMPE WHERES TOPQUEER 😂
1 · Reply
11thestate
11thestate May. 23 at 11:23 PM
$AMPE investors, if you follow us, you already knew about it. This is the good news you needed about $AMPE today. Go check it out. #AmpioPharmaceuticals #AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 16 at 12:20 PM
$AMPE agreed to a $3M settlement with investors over claims it misled them about the efficacy of its drug Ampion. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.15 per share — but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 16 at 11:49 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of Ampion in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between October 31, 2022 and January 13, 2025. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.15 per share — but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 15 at 12:07 PM
$AMPE stockholders filed a claim against Ampio Pharmaceuticals for misleading them about the efficacy results and disclosures related to its AP-013 clinical trial. You can join this case to be notified about potential recovery: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
11thestate
11thestate May. 9 at 12:11 PM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented Ampion’s effectiveness in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.15 per share, depending on how many investors file. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 2 at 12:12 PM
$AMPE agreed to a $3M settlement with investors over claims it misled the public about the effectiveness of its drug Ampion. Who’s eligible? Anyone who bought $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.15 per share, but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after the final approval hearing on February 19, 2025. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate Apr. 25 at 11:57 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of its Ampion drug. Who’s eligible? Anyone who purchased or otherwise acquired Ampio ($AMPE) common stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you’re eligible even if you still hold the shares, as long as you bought during the class period. How much is the payout? Estimated at $0.15 per share, depending on the number of valid claims submitted. Can I still file? Yes — late claims are being accepted, subject to court approval. When will payments go out? Payouts usually happen 8–12 months after the final approval hearing. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Apr. 21 at 12:56 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the effectiveness of its drug Ampion in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold later. How much is the payout? Estimated at $0.15 per share, depending on how many valid claims are filed. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Typically 8–12 months after final court approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Apr. 11 at 12:04 PM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
2 · Reply
11thestate
11thestate Apr. 4 at 10:23 AM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 30 at 12:25 PM
$AMPE Rough road for AMPE. OA-201 might be their last shot, but legal drama and cash burn are major red flags. Watching closely but skeptical. Not touching until more clarity emerges. compelling article: https://beyondspx.com/article/ampio-pharmaceuticals-ampe-a-tumultuous-journey-marked-by-setbacks-and-regulatory-challenges
0 · Reply
11thestate
11thestate Mar. 28 at 11:17 AM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Mar. 21 at 12:03 PM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
JoeShmoDoe
JoeShmoDoe Mar. 20 at 1:43 PM
$AMPE lmao. Major fail.
0 · Reply
molinavic2
molinavic2 Mar. 20 at 12:07 PM
$AMPE
0 · Reply